Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma.
Zhao JJ, Chu ZB, Hu Y, Lin J, Wang Z, Jiang M, Chen M, Wang X, Kang Y, Zhou Y, Ni Chonghaile T, Johncilla ME, Tai YT, Cheng JQ, Letai A, Munshi NC, Anderson KC, Carrasco RD.
Zhao JJ, et al. Among authors: munshi nc.
Cancer Res. 2015 Oct 15;75(20):4384-4397. doi: 10.1158/0008-5472.CAN-15-0457. Epub 2015 Aug 6.
Cancer Res. 2015.
PMID: 26249174
Free PMC article.